Levalbuterol HFA MDI followed by Racemic albuterol HFA MDI

DRUG3 trials

Sponsors

Sumitomo Pharma America, Inc.

Conditions

Asthma

Phase 2

A Safety and Tolerability Study of Levalbuterol HFA Metered Dose Inhaler in Subjects With Asthma

CompletedNCT00684827

Sumitomo Pharma America, Inc.Asthma

Start: 2002-10-31End: 2003-02-28Updated: 2012-02-22

Safety and Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatrics Subjects With Asthma

CompletedNCT00684866

Sumitomo Pharma America, Inc.Asthma

Start: 2003-01-31End: 2003-07-31Updated: 2012-02-22

Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma

CompletedNCT00685022

Sumitomo Pharma America, Inc.Asthma

Start: 2003-06-30End: 2003-08-31Updated: 2012-02-22